Rezulin (troglitazone) for Type II diabetes

January 1997

The FDA and the HPB are considering Rezulin (troglitazone) for Type II diabetes.

Troglitazone will be the first drug in a new class.

It helps reduce insulin resistance...an underlying metabolic defect in most patients with Type II diabetes.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

More discussions about increasing prescription drug information for patients
Antifungals Some patients take ketoconazole (Nizoral) tablets with a cola beverage
Antifungals Amphotericin B ORAL suspension
Antifungals New LIPID formulations of IV amphotericin B
Diabetes Computer software programs for diabetics
Diabetes Rezulin (troglitazone) for Type II diabetes
Contraceptives Closer look at vaginal spermicides
Contraceptives New oral contraceptive, Estrostep
Contraceptives Drug interactions with contraceptives
Alzheimer Disease Drugs that might help reduce the risk of Alzheimer's
Alzheimer Disease New drug to TREAT Alzheimer's called Aricept (donepezil)
Eating Disorders The new appetite suppressant, Redux (dexfenfluramine) for binge eating
Cardiology New COMBINATION drugs for hypertension
Cardiology Several alternatives for patients who get a chronic cough from ACE inhibitors
Cardiology Beta blockers to reduce the risk of heart attack or heart failure after surgery
Thrombolytics New thrombolytic, Retavase (reteplase)
Asthma Leukotriene antagonists for asthma
Women's Health Common symptom of menopause is oral discomfort
Practice Chart of significant new drugs approved by the FDA and HPB in 1996